BDBM285984 US10081617, Example 131::US10081617, Example 132::methyl [4-(2-{3-[5-chloro- 2-(1H-tetrazol-1-yl)phenyl]- 8-hydroxy-1-oxido-5,6,7,8- tetrahydroquinolin-8-yl}- 1H-imidazol-4- yl)phenyl]carbamate

SMILES COC(=O)Nc1ccc(cc1)-c1c[nH]c(n1)C1(O)CCCc2cc(c[n+]([O-])c12)-c1cc(Cl)ccc1-n1cnnn1

InChI Key

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 285984   

TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM285984(US10081617, Example 131 | US10081617, Example 132 ...)
Affinity DataIC50:  8.90nMpH: 7.4Assay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM285984(US10081617, Example 131 | US10081617, Example 132 ...)
Affinity DataIC50:  1.00E+3nMpH: 7.4Assay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent